The Role of MicroRNA-196a in Tumorigenesis, Tumor Progression, and Prognosis

Overview

Journal Tumour Biol

Publisher Sage Publications

Specialty Oncology

Date 2016 Oct 19

PMID 27752997

Citations 8

Authors

Zhen-Yao Chen

Xin Chen

Zhao-Xia Wang

Affiliations

Soon will be listed here.

Abstract

MicroRNAs are a large group of non-coding RNAs that have emerged as regulators of various biological processes, especially carcinogenesis and cancer progression. Recent evidence has shown that microRNA-196a (miR-196a) is upregulated in most types of tumors and involved in multiple biological processes via translational inhibition and mRNA cleavage, such as cell proliferation, migration, and invasion, mostly functioning as an oncogene. Dysregulation of miR-196a promotes oncogenesis and tumor progression. In this review, we summarize the upstream regulators, target genes, signaling pathways, and single nucleotide polymorphisms of miR-196a, which collectively affect cell proliferation, migration, and invasion. In addition, we review the clinical outcomes and significance of miR-196a. miR-196a may serve as a novel biomarker or target for diagnosis, prognosis, and therapy in several human cancers.

Citing Articles

The Association between Four Common Polymorphisms in microRNA and Risk of Hepatocellular Carcinoma: An Updated Meta-Analysis.

Chen M, Lu Y, Wang X, Qin S, Chen H, Lu L Iran J Public Health. 2023; 52(11):2272-2285.

PMID: 38106842 PMC: 10719708. DOI: 10.18502/ijph.v52i11.14027.

Expression of Selected miRNAs in Normal and Cancer-Associated Fibroblasts and in BxPc3 and MIA PaCa-2 Cell Lines of Pancreatic Ductal Adenocarcinoma.

Mandys V, Popov A, Gurlich R, Havranek J, Pfeiferova L, Kolar M Int J Mol Sci. 2023; 24(4).

PMID: 36835029 PMC: 9961675. DOI: 10.3390/ijms24043617.

The Role of Immune-Related miRNAs in the Pathology of Kidney Transplantation.

Bostjancic E, Veceric-Haler Z, Kojc N Biomolecules. 2021; 11(8).

PMID: 34439863 PMC: 8393721. DOI: 10.3390/biom11081198.

Integrated Interaction Network of MicroRNA Target Genes in Keloid Scarring.

Lyu L, Zhao Y, Lu H, Liu Z, Guo J, Lu D Mol Diagn Ther. 2019; 23(1):53-63.

PMID: 30604399 DOI: 10.1007/s40291-018-0378-0.

A voltammetric assay for microRNA-25 based on the use of amino-functionalized graphene quantum dots and ss- and ds-DNAs as gene probes.

Akbarnia A, Zare H Mikrochim Acta. 2018; 185(11):503.

PMID: 30302568 DOI: 10.1007/s00604-018-3037-6.

References

Lu Y, Chang J, Liao C, Kang C, Huang S, Chen I . OncomiR-196 promotes an invasive phenotype in oral cancer through the NME4-JNK-TIMP1-MMP signaling pathway. Mol Cancer. 2014; 13:218. PMC: 4176851. DOI: 10.1186/1476-4598-13-218. View

Boissan M, Lacombe M . Nm23/NDP kinases in hepatocellular carcinoma. J Bioenerg Biomembr. 2006; 38(3-4):169-75. DOI: 10.1007/s10863-006-9031-4. View

Kim H, Yoon J, Lee H, Cheong J, Cho S, Shin H . MicroRNA-196A-2 polymorphisms and hepatocellular carcinoma in patients with chronic hepatitis B. J Med Virol. 2013; 86(3):446-53. DOI: 10.1002/jmv.23848. View

Zhang J, Zheng F, Yu G, Yin Y, Lu Q . miR-196a targets netrin 4 and regulates cell proliferation and migration of cervical cancer cells. Biochem Biophys Res Commun. 2013; 440(4):582-8. DOI: 10.1016/j.bbrc.2013.09.142. View

Steele C, Oien K, McKay C, Jamieson N . Clinical potential of microRNAs in pancreatic ductal adenocarcinoma. Pancreas. 2011; 40(8):1165-71. DOI: 10.1097/MPA.0b013e3182218ffb. View

Li X, Li Z, Song X, Liu C . A variant in microRNA-196a2 is associated with susceptibility to hepatocellular carcinoma in Chinese patients with cirrhosis. Pathology. 2010; 42(7):669-73. DOI: 10.3109/00313025.2010.522175. View

Hou T, Ou J, Zhao X, Huang X, Huang Y, Zhang Y . MicroRNA-196a promotes cervical cancer proliferation through the regulation of FOXO1 and p27Kip1. Br J Cancer. 2014; 110(5):1260-8. PMC: 3950858. DOI: 10.1038/bjc.2013.829. View

Maru D, Singh R, Hannah C, Albarracin C, Li Y, Abraham R . MicroRNA-196a is a potential marker of progression during Barrett's metaplasia-dysplasia-invasive adenocarcinoma sequence in esophagus. Am J Pathol. 2009; 174(5):1940-8. PMC: 2671281. DOI: 10.2353/ajpath.2009.080718. View

Jin K, Park S, Teo W, Korangath P, Cho S, Yoshida T . HOXB7 Is an ERα Cofactor in the Activation of HER2 and Multiple ER Target Genes Leading to Endocrine Resistance. Cancer Discov. 2015; 5(9):944-59. PMC: 4560624. DOI: 10.1158/2159-8290.CD-15-0090. View

10.

Lee Y, Ahn C, Han J, Choi H, Kim J, Yim J . The nuclear RNase III Drosha initiates microRNA processing. Nature. 2003; 425(6956):415-9. DOI: 10.1038/nature01957. View

11.

Slaby O, Srovnal J, Radova L, Gregar J, Juracek J, Luzna P . Dynamic changes in microRNA expression profiles reflect progression of Barrett's esophagus to esophageal adenocarcinoma. Carcinogenesis. 2015; 36(5):521-7. DOI: 10.1093/carcin/bgv023. View

12.

Szafranska-Schwarzbach A, Adai A, Lee L, Conwell D, Andruss B . Development of a miRNA-based diagnostic assay for pancreatic ductal adenocarcinoma. Expert Rev Mol Diagn. 2011; 11(3):249-57. DOI: 10.1586/erm.11.10. View

13.

Xu X, Ling Q, Wang J, Xie H, Wei X, Lu D . Donor miR-196a-2 polymorphism is associated with hepatocellular carcinoma recurrence after liver transplantation in a Han Chinese population. Int J Cancer. 2015; 138(3):620-9. DOI: 10.1002/ijc.29821. View

14.

Gregory R, Chendrimada T, Cooch N, Shiekhattar R . Human RISC couples microRNA biogenesis and posttranscriptional gene silencing. Cell. 2005; 123(4):631-40. DOI: 10.1016/j.cell.2005.10.022. View

15.

Guan Y, Mizoguchi M, Yoshimoto K, Hata N, Shono T, Suzuki S . MiRNA-196 is upregulated in glioblastoma but not in anaplastic astrocytoma and has prognostic significance. Clin Cancer Res. 2010; 16(16):4289-97. DOI: 10.1158/1078-0432.CCR-10-0207. View

16.

Chen W, Cai F, Zhang B, Barekati Z, Zhong X . The level of circulating miRNA-10b and miRNA-373 in detecting lymph node metastasis of breast cancer: potential biomarkers. Tumour Biol. 2012; 34(1):455-62. DOI: 10.1007/s13277-012-0570-5. View

17.

Kong X, Du Y, Wang G, Gao J, Gong Y, Li L . Detection of differentially expressed microRNAs in serum of pancreatic ductal adenocarcinoma patients: miR-196a could be a potential marker for poor prognosis. Dig Dis Sci. 2010; 56(2):602-9. DOI: 10.1007/s10620-010-1285-3. View

18.

Thiery J, Acloque H, Huang R, Nieto M . Epithelial-mesenchymal transitions in development and disease. Cell. 2009; 139(5):871-90. DOI: 10.1016/j.cell.2009.11.007. View

19.

Lu Y, Chang J, Huang Y, Huang C, Chen W, Lee L . Combined determination of circulating miR-196a and miR-196b levels produces high sensitivity and specificity for early detection of oral cancer. Clin Biochem. 2014; 48(3):115-21. DOI: 10.1016/j.clinbiochem.2014.11.020. View

20.

Zhan J, Chen L, Chen Z, Yuan Y, Xie G, Sun A . A functional variant in microRNA-196a2 is associated with susceptibility of colorectal cancer in a Chinese population. Arch Med Res. 2011; 42(2):144-8. DOI: 10.1016/j.arcmed.2011.04.001. View